Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds.
Sign Up to like & getrecommendations! Published in 2018 at "Acta biomaterialia"
DOI: 10.1016/j.actbio.2018.08.016
Abstract: Antigenicity remains the primary barrier towards expanding the use of unfixed xenogeneic biomaterials in clinical applications. An unfixed xenogeneic biomaterial devoid of antigenicity, with maintained structural and mechanical integrity, has potential to overcome the limitations… read more here.
Keywords: immune; unfixed xenogeneic; residual antigenicity; graft specific ... See more keywords